Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition-Reference-Cited by-同舟云学术

Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Published:2018-05-28 Issue:7 Volume:24 Page:968-977
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Wong Gabrielle S.,Zhou Jin,Liu Jie Bin,Wu Zhong,Xu Xinsen,Li Tianxia,Xu David,Schumacher Steven E.,Puschhof Jens,McFarland James,Zou Charles,Dulak Austin,Henderson Les,Xu Peng,O’Day Emily,Rendak Rachel,Liao Wei-li,Cecchi Fabiola,Hembrough Todd,Schwartz Sarit,Szeto Christopher,Rustgi Anil K.,Wong Kwok-Kin,Diehl J. Alan^ORCID,Jensen Karin,Graziano Francesco,Ruzzo Annamaria,Fereshetian Shaunt,Mertins Philipp,Carr Steven A.^ORCID,Beroukhim Rameen,Nakamura Kenichi,Oki Eiji,Watanabe Masayuki,Baba Hideo,Imamura Yu,Catenacci Daniel,Bass Adam J.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-018-0022-x.pdf

Reference47 articles.

1. Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J. & Der, C. J. Drugging the undruggable RAS: mission possible? Nat. Rev. Drug Discov. 13, 828–851 (2014).

2. Ross, J. S. et al. Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies. Gynecol. Oncol. 130, 554–559 (2013).

3. Dulak, A. M. et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat. Genet. 45, 478–486 (2013).

4. Dulak, A. M. et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res. 72, 4383–4393 (2012).

5. Chen, Y. et al. Identification of druggable cancer driver genes amplified across TCGA datasets. PloS ONE 9, e98293 (2014).

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of KRAS amplification in patients with metastatic cancer: Real-world next-generation sequencing analysis;Pathology - Research and Practice;2024-09

2. Advances in SHP2 tunnel allosteric inhibitors and bifunctional molecules;European Journal of Medicinal Chemistry;2024-09

3. Identification of clinical prognosis features and significant DNA methylation regulation in pineoblastoma;International Journal of Clinical Oncology;2024-08-30

4. Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitors;Oncogene;2024-08-16

5. Molecular and Clinicopathological Correlates of Wild-Type KRAS Expression in Prostate Cancer;annals of urologic oncology;2024-07-28